Frontlight ResearchEarly access
WithdrawnNo phase
Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.
Key facts
- Who runs it
- Psychiatric University Hospital, Zurich
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Dec 2025
- Ended
- 1 Dec 2025
- Type of study
- Observational
- Treatments tested
- Antipsychotic
- Record updated
- 8 December 2025
- Why it stopped
- After screening, not enough participants fulfilled the inclusion criteria.
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Participants are competent to give informed consent
- Participants are between 18 and 65 years of age
- Diagnosis of schizophrenia DSM-5
- Violent crime in the course of a psychotic episode
- German language proficiency
Who cannot take part
- Current neurological disorder
- Substance induced psychotic disorder
- Low intelligence
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Considering the vulnerability of patients with schizophrenia in forensic treatment, we have designed a prospective-observational trial. The purpose of our study, notably its focus on selecting the appropriate medication, developing clinical profiles, and determining the grounds of clinical judgment, is relevant for treating patients with schizophrenia.
Treatments tested
- Antipsychotic
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study
- Publications
- Capacity to give informed consent in patients with severe mental disorder in different treatment settings.Frontiers in psychiatry, 2025
- Record updated
- 8 December 2025